NASDAQ
HAVN Life Sciences Inc. (HAVLF) has a eps (diluted) of $-5.25 as of Saturday, April 30, 2022. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.